The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism

James M Murphy1, Peter E Czabotar, Joanne M Hildebrand

  • 1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3050, Australia.

Immunity
|September 10, 2013
PubMed

Insights

Mixed lineage kinase domain-like (MLKL) is crucial for tumor necrosis factor-induced necroptosis. MLKL-deficient cells resist this cell death pathway, highlighting MLKL

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • Mixed lineage kinase domain-like (MLKL) is a key component of the necrosome complex.
  • The necrosome complex mediates tumor necrosis factor (TNF)-induced necroptosis, a form of programmed cell death.

Purpose of the Study:

  • To elucidate the specific role and molecular mechanism of MLKL in necroptosis.
  • To generate MLKL-deficient mice for functional studies and determine the MLKL structure.

Main Methods:

  • Generation and analysis of MLKL-deficient mice.
  • X-ray crystallography to solve the MLKL protein structure.
  • Site-directed mutagenesis to probe MLKL pseudoactive site function.

Main Results:

  • MLKL-deficient cells are resistant to TNF-induced necroptosis, confirming MLKL's essential role.
  • The crystal structure revealed MLKL's pseudokinase domain binds ATP but is catalytically inactive.
  • RIPK3-mediated phosphorylation induces MLKL's nonenzymatic function in necroptosis.
  • Mutations in the MLKL pseudoactive site lead to RIPK3-independent necroptosis.

Conclusions:

  • MLKL is indispensable for TNF-induced necroptosis signaling.
  • The pseudokinase domain's activity is regulated by RIPK3 phosphorylation, not intrinsic catalysis.
  • MLKL modification is critical for propagating the necroptosis pathway downstream of RIPK3.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...